Published On: Mon, Mar 31st, 2014

US Supreme Court agrees to hear Teva Copaxone appeal

copaxone_03

The US Supreme Court has agreed to hear an appeal by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) over the expiry of its patents for Copaxone, its treatment for multiple sclerosis. The hearing could delay the expiration of the drug’s US patents until September 2015. They patents are due to expire in May.

Read more about: , ,

Wordpress site Developed by Fixing WordPress Problems